NCT01615107

Brief Summary

The paucity of published data concerning the issue of mechanical labor induction in the setting of Term PROM has led us to undertake the present clinical trial. This study is designed to compare the efficacy and safety of the standard Oxytocin induction protocol with the double-balloon catheter device with concurrent oxytocin administration in patients with Term PROM and unfavorable cervical conditions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2012

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 8, 2012

Completed
23 days until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

June 8, 2012

Status Verified

April 1, 2012

Enrollment Period

2 years

First QC Date

April 23, 2012

Last Update Submit

June 6, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • PPROM/PROM to delivery interval

    Time from rupture of mambrane to delivery From hospitalization until delivery

    3year

Study Arms (2)

GROUP 1: Oxytocin infusion alone

EXPERIMENTAL

GROUP 1: Oxytocin infusion alone

Drug: PITOCIN

double balloonand oxytocin

EXPERIMENTAL

insertion of the double balloon and oxytocin

Device: COOK RIPENENIG BALLOON+PITOCNOther: double balloonand oxytocinOther: ballon and oxytocinProcedure: double balloonand and oxytocin

Interventions

GROUP 2: insertion of the double balloon device and concurrent oxytocin administration.

Also known as: BALLOON+PITOCN
double balloonand oxytocin

: Oxytocin infusion alone (Standard Protocol

Also known as: Oxytocin infusion alone
GROUP 1: Oxytocin infusion alone

balloonand oxytocin

Also known as: balloonand oxytocin
double balloonand oxytocin

double- balloon catheter device with concurrent oxytocin

Also known as: balloon catheter device with concurrent oxytocin
double balloonand oxytocin

balloon catheter device with concurrent oxytocin

Also known as: balloon catheter device with concurrent oxytocin
double balloonand oxytocin

Eligibility Criteria

Age16 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosed to be pregnant with PROM at \> 34 week
  • Found to have a Bishop score of 4 points or less.
  • Diagnosed as having a singleto
  • Willingness to comply with the protocol for the duration of the study.
  • Have signed an informed consent.

You may not qualify if:

  • Any contraindication for a vaginal deliver
  • Regular uterine contractn
  • Evidence of chorio-amonitis
  • Previous cesarean section or presence of any uterine scar.
  • Suspected placental abruption or presence of a significant hemorrhage.
  • Non-reassuring fetal statu

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hillel Yaffe Medical Center

Hadera, 38101, Israel

Location

Related Publications (1)

  • de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4.

MeSH Terms

Interventions

Oxytocin

Intervention Hierarchy (Ancestors)

Pituitary Hormones, PosteriorPituitary HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Study Officials

  • Elad Mei-Dan, DR

    Hillel Yaffe Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elad Mei-Dan, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2012

First Posted

June 8, 2012

Study Start

July 1, 2012

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

June 8, 2012

Record last verified: 2012-04

Locations